HANDOK Inc.
002390 | KO
Overview
Corporate Details
- ISIN(s):
- KR7002390003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 테헤란로 132, 서울특별시
- Website:
- https://www.handok.co.kr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-16 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 17.3 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.8 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 20.6 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.9 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.9 KB | ||
| 2025-08-18 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 18.7 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 4.1 MB | ||
| 2025-08-05 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 23.7 KB | ||
| 2025-07-31 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 17.3 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 20.6 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.4 KB | ||
| 2025-06-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 118.7 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 1000.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.7 MB |
Automate Your Workflow. Get a real-time feed of all HANDOK Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HANDOK Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HANDOK Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden
CHOSA
Sweden
CHOSA
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan
4519
Japan
4519
Direct-to-home service providing medicine boxes, health products, and daily necessities.
Japan
4558
Japan
4558
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America
CDTX
United States of America
CDTX
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden
CINPHA
Sweden
CINPHA
Developing once-daily, precision timed-release drugs for ADHD and anxiety.
United States of America
CING
United States of America
CING
Commercializing LYMPHIR™, an FDA-approved targeted therapy for cutaneous T-cell lymphoma.
United States of America
CTOR
United States of America
CTOR
Late-stage biopharma developing critical care products for oncology, infections, and stem cells.
United States of America
CTXR
United States of America
CTXR